Search All News
CancerFIT—a free exercise program at CUIMC for cancer patients and survivors—offers more than a physical workout, it also provides much-needed support and inspiration.
Columbia biomedical engineers have designed a bacteria strain that seeks out solid tumors and safely delivers immunotherapies, resulting in tumor regression in mouse models.
The three scientists honored by the 2019 Horwitz Prize played key roles in identifying and deciphering the PI3K pathway, which has led to new treatments for several types of cancer.
By learning how contagious cancer spreads among shellfish, scientists hope to better understand how cancer metastasizes in people.
Source:Washington PostJune 4, 2018
- June 4, 2018
Joint pain relief from omega-3s may help more women adhere to hormonal breast cancer treatment, a study suggests.
- May 4, 2018
An experimental immunotherapy improved one-year survival, as compared to historical rates, in a small trial of patients with advanced uveal melanoma.
- April 10, 2018
A new Science study from Columbia stem cell researchers has found that the liver is the surprising source of a growth factor that keeps bone marrow stem cells healthy.
- April 5, 2018
3-D organoids created from the bladder cancers of patients mimic the characteristics of each patient’s tumor and may be used in the future to identify the best treatment for each patient.
- March 30, 2018
Though far from the most common form of cancer, brain cancers are uniquely difficult to treat. Columbia scientists are researching multiple new ways to attack the tumors.
- February 28, 2018
Pathology’s new recruit, Kevin Gardner, talks about health disparities and the need for more diversity among research participants.
- February 21, 2018
Two new precision medicine tests that look beyond cancer genes to identify novel therapeutic targets are now available to both oncologists and cancer researchers.
- February 12, 2018
A new optical imaging system developed at Columbia University uses red and near-infrared light to identify breast cancer patients who will respond best to chemotherapy.
- January 24, 2018
A mutation that leads to relapse in many leukemia patients also causes a weakness that could be exploited to kill the cancer cells, Columbia researchers have reported.